As part of its collaborative mission, IBRI has entered into partnership agreements with academic institutions and industry to invest in people and build capabilities that enhance the overall research footprint of the institute. Partners include:
The Center for Diabetes and Metabolic Diseases (CDMD) at the Indiana University School of Medicine is an NIH-funded diabetes research center that includes more than seventy investigators engaged in basic and translational research in diabetes and related metabolic disorders, and their complications. The CDMD also houses four Research Cores that serve as a vital resource for innovative and translational research.
The Clinical and Translational Sciences Institute (CTSI) is a statewide collaboration of Indiana University, Purdue University, and the University of Notre Dame, as well as public and private partnerships, which facilitates the translation of scientific discoveries in the lab into clinical trials and new patient treatments in Indiana and beyond.
Cook Medical is the world’s largest private medical device manufacturer, specializing in vascular complications and regenerative medicine.
Dow AgroSciences focuses its research and development on innovative chemical and biotechnology solutions to meet the food, feed, and fiber needs of the world. The company delivers a broad range of technologies in plant genetics and food production, including agricultural chemicals, biotechnology and germplasm.
Eli Lilly and Company is a global leader in the development of insulin and diabetes medicines and was the first company to make insulin commercially available. The company continues its leadership position by being the first to bring a wide variety of diabetes advancements to market.
Indiana University Health is a statewide system with more than 20 partner hospitals and health centers throughout Indiana. As an academic medical center, IU Health is associated with Indiana University School of Medicine, one of the nation's largest medical schools and the site of thousands of research projects and clinical trials.
Roche Diagnostics, through a complete test portfolio specific to metabolism, as well as through self-testing solutions for patients, is the market leader in diagnosis and monitoring of diabetes and metabolic disorders.